Schedule 13G ownership disclosure

HEPION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 426897104

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
295,880
Percent of class
0.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-21-000039
Form type
SC 13G/A
Filer
Hepion Pharmaceuticals, Inc.
CIK
CIK 1583771
Filed
Feb 09, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub